In this paper, we combine inverse problem and classification for LC-MS data in a joint Bayesian context, given a set of biomarkers and the statistical characteristics of the biological classes. The data acquisition is modelled in a hierarchical way, including random decomposition of proteins into peptides and peptides into ions associated to peaks on the LC-MS measurement. A Bayesian global inversion, based on the hierarchical model for the direct problem, enables to take into account the biological and technological variabilities from those random processes and to estimate the parameters efficiently.
INTRODUCTION
Proteins of an organism are differently expressed according to biological states (healthy, pathological). Those specific proteomic profiles can be used for diagnosis, early detection, therapy planning and follow-up, drug development, etc [1] . Nevertheless, the reconstruction of proteomic profiles remains a challenge due to small and variable concentration of the biomarkers. Furthermore, biomarkers are present within a large protein content including an abundance ratio of up to 10 8 , hence the need to recognise efficiently the biomarkers on molecular profiles.
The reconstruction task has been tackled by several methods: non parametric methods such as area under peak, PLS, N-PLS, PARAFAC [2] , parametric methods based either on deterministic least square fitting or on other statistical estimation using for example Bayesian inference [3, 4] . Diagnosis based on proteomic profiles has been shown specific and sensitive [3] .
In this communication, our aim is to evaluate the biological state of a sample from a LC-MS (Liquid Chromatography, Mass Spectrometer) measurement. In order to do so, we will develop a classification method in order to optimise diagnoses and their degree of belief.
MS approaches are very attractive to detect protein panels in a sensitive and high speed way. MS can be coupled to many separation techniques. In our development, an LC is used. The physical model of the instrument has been realised by [2] . According to the analytical chain, proteins have to be digested into peptides before introduction into the LC. They will be ionised afterwards to be injected x x ion LC-MS measurement y in the MS. Both steps are subject to fluctuating behaviour which introduces a technological variability [5] . The biomarker distributions are needed for the classification processing. They can be determined by different procedures: given by an expert, or learnt either on estimations of the biomarker concentrations or on the spectrograms themselves.
In this paper, a hierarchical Bayesian approach to solving the underlying inverse problem is presented. By adopting an inverse problem framework, information about the variables, the instrument, the hierarchical structure, and the molecular interactions are included. The joint posterior distribution for the parameters is expressed, including the hierarchical structure [6, 7] . The global processing makes use of the technological and the biological variabilities which leads to more robust results compared to a succession of step by step processing [8, 9] . This task is not trivial since the proposed approach deals with both continuous and discrete variables.
Classification can be done after estimation of the protein concentration, or directly on the data without estimating other variables. In the proposed method, the originality is to combine inversion and classification by approximating the posterior for all parameters. Finally, estimating the biological state is equivalent to a classification processing.
This document is structured in the following manner. In section 2, the main theory for the development is exposed. Its application within an algorithm is described in section 3. Results are discussed in section 4 before concluding in section 5. 978-1-4577-0570-0/11/$26.00 ©2011 IEEEorder to introduce the sample into the LC-MS, the selected proteins are digested into peptides. The digestion gain is described by a deterministic matrix D ∈ N P ×I translating the number of copies of peptide i = 1, . . . , I produced by protein p = 1, . . . , P [2, ch. 2]. The peptide concentration is denoted κ. None the less, this process is fluctuating, leading to an incomplete digestion. Within the instruments, the peptides are separated by their retention time T in the LC and are subjected to a system gain ξ, characterising in particular the ionisation and the injection within the MS. These steps, in addition to a white Gaussian noise of precision γn, lead to the output data y (see Fig. 1 ).
The system is calibrated by using the PSAQ standardisation method which adds isotopic standards of the biomarkers in known quantity to the initial sample [10] . Theses standards are then subjected to the same gains and variabilities than the target proteins, hence they bring information to estimate gains.
Prior distributions
As shown in Fig. 1 , variables are grouped together and referred to as biological and technological parameters, according to the description above. The biological parameter vector θ bio of this framework only contains the concentration c. The technological parameters are those involved in the instrument, so θ tech = (κ, ξ, T , γn). With respect to the hierarchical structure and to the prior knowledges, we choose a normal distribution for the data y given the parameters which is also the total likelihood p(y|θ tech ) = N(y; Hκ, Γn). The system matrix H = H(ξ, T ) expresses the linearity between the data and the peptide concentration. The diagonal matrix Γn = γn I is the noise precision (inverse covariance) with I the identity matrix. By doing so, the noise is modelled with the same level on the whole data.
The conditional prior distribution for θ tech is given by the product of the conditional priors for each component. We choose following distributions:
• normal for the gain, p(ξ) = N(ξ; ξ0, Γ ξ ) with mean ξ0 and precision Γ ξ ; • uniform for the retention time, p(T ) = U(T min , T max ) where T min is the lower and T max the upper bound of the allowed interval for T ;
• Gamma for the inverse variance of the noise, p(γn) = G(γn; αn, βn) where αn and βn are the steering parameters of the distribution; • normal for the peptide concentration given the protein concentration c, p(κ|c) = N(κ; Dc, Γκ) with mean Dc and precision Γκ, D being the digestion matrix (see [2] ).
As regards the distribution for θ bio , only the distribution for the protein concentration has to be considered. This distribution is crucial for the classification since it describes the different laws between the healthy (B = H) and the pathological case (B = P ). A normal distribution is attributed to protein concentration prior conditionally on the biological state, p(c|B) = N(c; mB, ΓB) with mean mB and precision ΓB depending on the biological state B. That is, by marginalising B, the distribution for c is characterised as a Gaussian mixture model. Finally, to complete the prior, we choose a Bernoulli distribution for the biological state B, Pr(B) = pB ≥ 0 with pH + pP = 1.
All distributions have been chosen for their good approximation of the real process and for their ability for simple calculations. The total joint distribution is
In this work, non informative priors are chosen for all variables except T since the retention time for a peptide is known in a temporal interval. The non-informativity for the variables with normal prior is reached by tending the precisions to zero. For the noise level γn, this is done by choosing a Jeffreys prior [6, Appendix A].
Statistical joint posterior for inversion/classification
We use the joint posterior distribution, p(B, θ bio , θ tech |y), given by Bayes' rule as ratio of the joint distribution and the marginalised distribution for y. In order to classify, the posterior probability of the biological states has to be calculated, i.e. Pr(B = H|y) and Pr(B = P |y). For this, all parameters except B are marginalised in the joint posterior:
By integrating them out, all their jointly possible values (biological and technological variability) are considered. Classification is then done by the posterior maximiser of B, i.e.
B = arg max
For other decision methods, see [7, sect 5.2] . The posterior mean (PM) given the stateB of the other parameters is calculated:
(4) This integrates again the variabilities that we have already mentioned and uses the same posterior distribution as in (2) . The PM is chosen for the minimisation of the mean quadratic error [7, sect. 2.5] .
Solving equations (2) and (4) is analytically impossible. We thus approximate the joint posterior distribution using the MCMC method [6, ch. 11 ]. This will allow both to marginalise the parameters in equation (2) and to compute the estimator in (4).
IMPLEMENTATION
In order to compute the joint posterior by an MCMC method, a Gibbs structure is adopted to transform a global problem into several simpler subproblems. The conditional posteriors for each subproblem depend only on a reduced number of parameters due to the hierarchy [7, sect. 10.2] . Taking into account the conditional independences within each level of hierarchy, the conditional posterior for a parameter is proportional to the product of only its (conditional) prior and the corresponding likelihood (see Sect. 2.2). As an example, the protein concentration is independent from all parameters given the peptide concentration and the biological state: p(c|ξ, T , κ, γn, B) = p(c|κ, B). This simplifies the algorithm.
The conditional posteriors for the concentrations (proteins and peptides), the gains and the noise precision are of the same family as their prior respectively, since their priors are conjugated by the corresponding conditional likelihood. Recalling the last example, the conditional posterior for the protein concentration is a Gaussian Alg. 1 -Pseudo-code of the algorithm used for the Bayesian classification and estimation.
1. initialisation, allocation 2. Gibbs loop
. approximation of Pr(B|y) by histogramming on marginalised samples of B (k) , k = K0 + 1, . . . , K0 + K, and returnB = arg max B∈{H,P } Pr(B|y).
4. approximation of PM ĉ,κ,T ,ξ,γn by averaging the Due to the non informative priors, the conditional posterior distribution for a parameter is determined only by the parameters on its hierarchical level and those below it in Fig. 1, i .e. the level above does not contribute to the conditional posterior here.
For all parameters, sampling is possible. Except for the retention time T , the prior is conjugated by the likelihood, i.e. the conditional posterior is of the same family as the prior. Within the Gibbs algorithm, this allows for an explicit sampling of these parameters. As to T , a Metropolis-Hastings Random-Walk step is introduced into the Gibbs loop [6, sect. 11.5] . This is notably a good compromise between an Independent Metropolis-Hastings having fast computation, but slow convergence properties and sophisticated MH methods such as Langevin, Hessian or Hamiltonian updates having slow computation but fast convergence properties [6, ch. 13], [11] . With this method, the sample distribution converges to the posterior distribution, with only little computational effort.
Finally, having simulated enough samples, we approximate the PM and the posterior state probability:
• Probability of the biological state is obtained by marginalisation of all parameters, see Sect. 2.3. Since we sample under the joint posterior, the marginalisation is done by histogramming the samples for B, regardless the other variables. This empirical probability is used to determine the posterior maximiser MAP,B, by the state with the highest empirical probability.
• The conditional posterior mean of the continuous variables is approximated by the empirical average of the samples k such that B (k) =B.
Note that in both cases, we allow for a burn-in period to adjust the distributions since the first samples are not distributed under the posterior [6, sect. 11.6]. We choose arbitrarily to consider only the second half of the samples. The algorithm is summarised in Alg. 1.
RESULTS
Testing cohorts of 200 healthy and 200 pathological samples with one biomarker were created, using the instrument model exposed in [4] , based upon real data parameters from former studies [3] . In the healthy cohort, the true protein concentration is distributed under p (c|H) = N(c; m H , γ H ) of mean m H = 50 and precision γ H = 0.2, in the pathological cohort, proteins are distributed under p (c|P ) = N(c; m P , γ P ) of mean m P = 70 and precision γ P = 0.2. These distributions correspond to the biological variability. From one experiment to another, technological variability has been simulated by using different values for θ tech . The characteristic distributions for each cohort are learnt from 100 learning samples for each biological state using [12] . They are given by p(c|H) = N(c; mH , γH ) and p(c|P ) = N(c; mP , γP ), where mH = 50.04, mP = 70.13, γH = 0.12, γP = 0.11. The learnt Gaussian distributions are wider than the cohort simulation distributions because of the incertitudes in the learning process.
The quantification part of the presented method has been tested successfully on simulated data with one biomarker. Fig. 2(a) demonstrates the dynamic of the sampler. A burn-in period is necessary for the samples being drawn under the posterior distribution. For the sake of convenience, only the marginalised draws for the concentration are shown. After a short period, the concentration samples are drawn under the posterior distribution. In Fig. 2(b) , we present the marginalised histogram of the protein concentration from a simulated data with true concentration of 50.07. In contrary to the flat, non informative prior distribution for the concentration, one can see a peaked Gaussian shape with a mean near to the true concentration.
Using the test set, empirical probabilities have been approximated. In Fig. 2(c), a histogram showing the degree of belief in Bn = H is presented. Firstly, the figure describes that all tested data have been classified correctly since the classification is done upon the empirical posterior probability for the biological states. The false detection rate, i.e. Pr(B = B|B = B ), with B = B , is zero. Secondly, the degree of belief expresses the method's certitude in its estimation, given by the empirical probability for the estimated biological state. In the given configuration, the certitude in the classification is of 96% or higher which reflects as well the probability of membership to the estimated biological state. In other words, for nearly all data, the probability that biological state given the data is the estimated one is 100%, so one can be sure to classify correctly.
The considered configuration favours good estimations since the classes are well separated. As the mean mP of the pathological class approaches the mean mH of the healthy class, the classification performance naturally decreases. The distance of the two considered classes can be measured by the Kullback-Leibler-divergence. We define de Right Decision Rate (RDR) as the ratio of number of right estimations over the total number of estimations, and the False Decision Rate (FDR) as the ratio of number of false estimations over the total number of estimations, corresponding to a Type-I-error.
The results of the performances are shown in Tab. 1. For KL greater than 6.83, no false estimation is done, that is the FDR is 0.
For common values of the FDR, i.e. 5% and 10%, the classification with the presented method is still done satisfactorily with class distributions that are near and, thus, overlapping each other (KL ≈ 4.60 and KL ≈ 2.79 respectively).
CONCLUSION
In this paper, we presented an original way of combining inverse problem and classification in proteomics by using an indirect mea- surement of the classifying variable in a LC-MS spectrum. We have shown that this approach yields good results which are robust due to the probabilistic direct modelling of each biological and technical step and the corresponding statistical inversion. This framework improves both the classification and the quantification when the prior on the concentration is conditioned by the class of the samples. This will allow to combine within the same statistical framework quantitative and differential proteomic analysis.
Later on, the multivariate approach will allow to describe possible interactions between proteins. The work is transposable to any comparison or differential analysis, other than diagnostics.
We restricted this work to a binary classification, but a classification with more classes, such as different pathologies or different states of the same pathology, can also be performed.
